These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 6190540)
21. The natural history of benign prostatic hyperplasia. Harv Mens Health Watch; 1998 Mar; 2(8):1-5. PubMed ID: 9516320 [No Abstract] [Full Text] [Related]
22. [Functional morphology of the hypophyseal-adrenal-gonad system in different variants of prostatic hyperplasia]. Iushkov PV; Morozov AG Arkh Patol; 2001; 63(2):11-6. PubMed ID: 11392085 [TBL] [Abstract][Full Text] [Related]
24. Benign prostatic hyperplasia: a review of its histogenesis and natural history. Oesterling JE Prostate Suppl; 1996; 6():67-73. PubMed ID: 8630233 [TBL] [Abstract][Full Text] [Related]
26. [Urology: sperm production and prostate reduction]. Böhlen D; Hochreiter WW; Thalmann GN; Danuser HJ Schweiz Med Wochenschr; 1998 Jan; 128(1-2):38-41. PubMed ID: 9491470 [No Abstract] [Full Text] [Related]
27. Comparative pathology of benign prostatic hyperplasia and prostate cancer. Maini A; Archer C; Wang CY; Haas GP In Vivo; 1997; 11(4):293-9. PubMed ID: 9292295 [TBL] [Abstract][Full Text] [Related]
28. Salient and co-morbid features in benign prostatic hyperplasia: a histopathological study of the prostate. Shakya G; Malla S; Shakya KN Kathmandu Univ Med J (KUMJ); 2003; 1(2):104-9. PubMed ID: 16388207 [TBL] [Abstract][Full Text] [Related]
29. [Diagnostic problems in prostatic pathology: microglandular lesions and intraductal epithelial proliferations]. Berger N; Borda A Arch Anat Cytol Pathol; 1996; 44(4):141-59. PubMed ID: 9157823 [TBL] [Abstract][Full Text] [Related]
30. Leukemic infiltration of the prostate: a reversible form of urinary obstruction. Mitch WE; Serpick AA Cancer; 1970 Dec; 26(6):1361-5. PubMed ID: 4098491 [No Abstract] [Full Text] [Related]
31. [Ultrastructural studies of the detrusor in patients with benign prostatic hyperplasia]. Loran OB; Vishnevskiĭ AE; Sekamova SM Urol Nefrol (Mosk); 1996; (4):27-31. PubMed ID: 8928345 [TBL] [Abstract][Full Text] [Related]
32. [Epidemiological aspects of benign prostatic hypertrophy]. Valenti M; Necozione S; Di Orio F J Urol (Paris); 1993; 99(6):283-7. PubMed ID: 7516367 [No Abstract] [Full Text] [Related]
36. [Pathogenesis of prostatic carcinoma. II. The relation between precancerous lesions and carcinoma of the prostate]. Wu RL Zhonghua Zhong Liu Za Zhi; 1984 May; 6(3):189-91. PubMed ID: 6210185 [No Abstract] [Full Text] [Related]
37. Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review. Alcaraz A; Hammerer P; Tubaro A; Schröder FH; Castro R Eur Urol; 2009 Apr; 55(4):864-73. PubMed ID: 19027219 [TBL] [Abstract][Full Text] [Related]
38. Prostatic intraepithelial neoplasia in TURP specimens and subsequent prostate cancer. Meyer F; Têtu B; Bairati I; Lacombe L; Fradet Y Can J Urol; 2006 Oct; 13(5):3255-60. PubMed ID: 17076947 [TBL] [Abstract][Full Text] [Related]
39. Screening of prostate cancer in males with prostatism. Saxena S; Mohanty NK; Jain AK Indian J Pathol Microbiol; 1997 Oct; 40(4):441-50. PubMed ID: 9444853 [TBL] [Abstract][Full Text] [Related]
40. [Relation between benign prostatic hyperplasia and obesity and estrogen]. Matsuda T; Abe H; Suda K Rinsho Byori; 2004 Apr; 52(4):291-4. PubMed ID: 15164594 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]